Our lab is proud to announce our recent publication in Cell Reports Medicine, shedding light on a crucial mechanism behind muscle loss in cancer patients. This study, led by Aylin Domaniku-Waraich and team, demonstrates how Oncostatin M signaling can significantly impact muscle atrophy, presenting a potential target for therapeutic intervention. Understanding these pathways is vital for developing strategies to preserve muscle mass and function, ultimately improving patient outcomes. Read the full article to explore how this discovery could change the landscape of cancer treatment.
🔗 Link to the Full Article: https://doi.org/10.1016/j.xcrm.2024.101498
